Offer - Urjas Oil for just ₹ 1 X
Udilan 40 Tablet SR is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Premature Labor. Secondary and off-label uses of Udilan 40 Tablet SR have also been mentioned below.
The correct dosage of Udilan 40 Tablet SR depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Udilan 40 Tablet SR side effects, there are can be others also. These have been listed below. These side effects of Udilan 40 Tablet SR are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Udilan 40 Tablet SR has a Moderate effect for pregnant women and Mild effect on lactating mothers. It is important to know if Udilan 40 Tablet SR has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Udilan 40 Tablet SR related warnings section.
Udilan 40 Tablet SR can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Udilan 40 Tablet SR in conditions like Bleeding, Heart Disease.
Drug reaction of Udilan 40 Tablet SR with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Udilan 40 Tablet SR is not safe while driving, and is is not addictive in nature.
Udilan 40 Tablet SR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Adult |
|
Geriatric |
|
Is the use of Udilan 40 Tablet SR safe for pregnant women?
Udilan may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Udilan again without your doctor's advice.
Is the use of Udilan 40 Tablet SR safe during breastfeeding?
Udilan may have very limited harmful effects for breastfeeding women.
What is the effect of Udilan 40 Tablet SR on the Kidneys?
In the absence of any research, there are no known side effects of Udilan on kidneys.
What is the effect of Udilan 40 Tablet SR on the Liver?
So far, no research has been carried out on the effects of Udilan on the liver. So it is not known whether taking Udilan will affect the liver or not.
What is the effect of Udilan 40 Tablet SR on the Heart?
Udilan has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Udilan 40 Tablet SR unless your doctor advises you to do so -
Is this Udilan 40 Tablet SR habit forming or addictive?
No, there is no any evidence that Udilan 40 Tablet SR is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Udilan 40 Tablet SR can make you feel drowsy.
Is it safe?
Yes, Udilan 40 Tablet SR is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Udilan 40 Tablet SR for mental disorders.
Interaction between Food and Udilan 40 Tablet SR
Due to a lack of research, nothing can be said about the consequences of taking Udilan 40 Tablet SR together with food.
Interaction between Alcohol and Udilan 40 Tablet SR
It is difficult to say anything about the effect of Udilan 40 Tablet SR and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136